Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Volitionrx Ltd (NY: VNRX ) 0.6045 +0.0545 (+9.91%) Official Closing Price Updated: 8:00 PM EDT, Nov 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 51,178 Open 0.5884 Bid (Size) 0.5700 (1) Ask (Size) 0.6100 (1) Prev. Close 0.5500 Today's Range 0.5700 - 0.6299 52wk Range 0.4301 - 1.230 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Life Sciences Virtual Investor Forum Agenda Announced for September 19th September 16, 2024 Company Executives Share Vision and Answer Questions Live at VirtualInvestorConferences.com From Virtual Investor Conferences Via GlobeNewswire VNRX Stock Earnings: VolitionRX Beats EPS, Misses Revenue for Q2 2024 August 14, 2024 VNRX stock results show that VolitionRX beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. Via InvestorPlace Performance YTD -42.43% -42.43% 1 Month -20.44% -20.44% 3 Month +6.03% +6.03% 6 Month -22.43% -22.43% 1 Year -25.29% -25.29% More News Read More BioMedNewsBreaks — VolitionRx Limited (NYSE American: VNRX) appoints PharmaVentures for Capture PCR(TM) and Oncology Portfolio Licensing July 10, 2024 Via Investor Brand Network Earnings Outlook For VolitionRX March 22, 2024 Via Benzinga Earnings Preview: VolitionRX November 13, 2023 Via Benzinga BioMedNewsBreaks — VolitionRx Limited (NYSE American: VNRX) Highlights Latest Achievements in Mid-Year Review June 28, 2024 Via Investor Brand Network Topics Intellectual Property Exposures Intellectual Property Nexalin Technology and VolitionRX Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV June 14, 2024 Via ACCESSWIRE VNRX Stock Earnings: VolitionRX Beats EPS, Misses Revenue for Q1 2024 May 13, 2024 Via InvestorPlace VolitionRx Ltd. (NYSE American: VNRX) Featured in Coverage of the EF Hutton Annual Global Conference May 06, 2024 Via Investor Brand Network 12 Health Care Stocks Moving In Tuesday's Intraday Session April 23, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session April 23, 2024 Via Benzinga VNRX Stock Earnings: VolitionRX Meets EPS, Misses Revenue for Q4 2023 March 25, 2024 Via InvestorPlace Earnings Scheduled For March 25, 2024 March 25, 2024 Via Benzinga Next Big Thing: 3 Biotech Stocks to Watch for Groundbreaking Advances January 18, 2024 Via InvestorPlace Topics Economy Exposures Economy 12 Health Care Stocks Moving In Wednesday's Pre-Market Session January 03, 2024 Via Benzinga Why Trinity Place Holdings Shares Are Trading Higher By 80%; Here Are 20 Stocks Moving Premarket January 03, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session January 02, 2024 Via Benzinga IO Biotech And 2 Other Stocks Under $2 Insiders Are Buying November 27, 2023 Via Benzinga Topics Stocks Exposures US Equities Ondas Holdings And 2 Other Stocks Under $1 Insiders Are Buying November 20, 2023 Via Benzinga Topics Stocks Exposures US Equities Top 4 Health Care Stocks That Are Preparing To Pump This Quarter October 06, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session September 22, 2023 Via Benzinga Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session September 22, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session September 22, 2023 Via Benzinga Stocks That Hit 52-Week Lows On Tuesday September 19, 2023 Via Benzinga ReWalk Robotics And 3 Other Stocks Under $2 Insiders Are Buying September 07, 2023 Via Benzinga Topics Stocks Exposures US Equities Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
